ArticleJournal of gastrointestinal cancer2026
Characterization of Lymphocyte Subsets in Peripheral Blood of Patients with Colorectal Cancer.
Article in Journal of gastrointestinal cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeCellular immune response to cancer is known to be of great importance for tumor control. Until now, the role of systemic immune profiles in tumor progression remains unclear.
methodsBy using multiparameter flow cytometry, the subset distribution and immunophenotype of lymphocyte subsets were investigated in peripheral blood mononuclear cell samples from 117 colorectal cancer (CRC) patients and 77 healthy donors.
resultsCompared with the normal group, the numbers of T lymphocytes and Th lymphocytes were significantly decreased in the CRC group, whereas the number of NK cells was significantly increased. There was no significance between the two groups in the numbers of Ts, γδT, and CD4 + /CD8 + lymphocytes. The number of T lymphocytes was significantly increased after surgical resection, however, the number of B lymphocytes was significantly decreased. There was no significance in the number of other lymphocyte subsets neither before nor after rection. The number of NK cells increased in stage III-IV, as compared to stage I-II. The numbers of Ts and CD4 + /CD8 + lymphocytes showed a correlation with the tumor differentiation degree. The number of T lymphocytes was higher in conditions that were without lymph node invasion and distant metastasis. The number of CD4 + /CD8 + lymphocytes was significantly higher in the condition without perineural invasion.
conclusionThe altered phenotype of circulating immune cell subsets in CRC and its association with clinical outcome may facilitate the development of new therapeutics against CRC, and thereby contributing to better insight into the role of systemic immune profiles in tumor progression.
Indexed as
Identifiers
41746466What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.